Leptin Neutralization Attenuates Inflammaging In Endothelial And Immune Cell Models
As we age, our bodies can experience a state of chronic, low-grade inflammation, a process scientists call “inflammaging.” This persistent inflammation is a key contributor to many age-related diseases. Researchers have been investigating the factors that fuel this process, and one molecule of interest is leptin.
Leptin is a hormone primarily known for its role in regulating appetite and metabolism. However, it also acts as a signaling molecule that can promote inflammation. While its link to inflammation in conditions like obesity is well-established, its specific contribution to age-related inflammation was less understood.
A recent study explored what happens when the effects of leptin are blocked in various cell models relevant to inflammaging. These models included endothelial cells (which line our blood vessels) that were showing signs of aging, as well as immune cells like macrophages and T cells exposed to stressors such as high sugar levels or bacterial components.
The findings revealed that neutralizing leptin significantly reduced markers of aging and inflammation in these cells. For instance, in endothelial cells, blocking leptin suppressed the release of pro-inflammatory substances and reduced signs of cellular aging. Similarly, in macrophages, leptin blockade blunted inflammation induced by high sugar or bacterial toxins. In certain types of T cells, neutralizing leptin also led to a decrease in inflammatory and aging indicators.
These results suggest that leptin plays a role in driving inflammaging across different cell types. This discovery opens up new avenues for research, indicating that targeting leptin pathways could potentially be a strategy to mitigate age-related inflammation and, consequently, reduce the risk of associated diseases.
Source: link to paper